Inspire Investing’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-73,887
| Closed | -$315K | – | 817 |
|
|
2023
Q2 | $315K | Buy |
73,887
+33,962
| +85% | +$145K | 0.04% | 461 |
|
|
2023
Q1 | $273K | Buy |
39,925
+9,482
| +31% | +$64.9K | 0.03% | 596 |
|
|
2022
Q4 | $241K | Buy |
30,443
+9,283
| +44% | +$73.5K | 0.03% | 358 |
|
|
2022
Q3 | $203K | Sell |
21,160
-8,095
| -28% | -$77.7K | 0.03% | 739 |
|
|
2022
Q2 | $212K | Buy |
29,255
+11,125
| +61% | +$80.6K | 0.03% | 491 |
|
|
2022
Q1 | $234K | Buy |
18,130
+2,936
| +19% | +$37.9K | 0.03% | 675 |
|
|
2021
Q4 | $242K | Buy |
15,194
+1,994
| +15% | +$31.8K | 0.03% | 767 |
|
|
2021
Q3 | $212K | Buy |
+13,200
| New | +$212K | 0.03% | 782 |
|
|
2020
Q3 | – | Sell |
-12,648
| Closed | -$226K | – | 453 |
|
|
2020
Q2 | $226K | Sell |
12,648
-189
| -1% | -$3.38K | 0.08% | 366 |
|
|
2020
Q1 | $208K | Buy |
+12,837
| New | +$208K | 0.08% | 406 |
|
|
2018
Q1 | – | Sell |
-6,431
| Closed | -$57K | – | 290 |
|
|
2017
Q4 | $57K | Buy |
+6,431
| New | +$57K | 0.05% | 454 |
|